FRAXIPARINE 3800UI AFXa/0.4ml 3800 ui AFXa/0.4ml solution for injection ASPEN
nadroparin Indicated for: prevention and treatment of thromboembolism
letter F · page 37
nadroparin Indicated for: prevention and treatment of thromboembolism
nadroparin Indicated for: prevention and treatment of thromboembolism
nadroparin Indicated for: prevention and treatment of thromboembolism
nadroparin Indicated for: prevention and treatment of thromboembolism
nadroparin Indicated for: prevention and treatment of thromboembolism
nadroparin Indicated for: prevention and treatment of thromboembolism
nadroparin Indicated for: prevention and treatment of thromboembolism
nadroparin Indicated for: prevention and treatment of thromboembolism
nadroparin Indicated for: prevention and treatment of thromboembolism
nadroparin Indicated for: prevention and treatment of thromboembolism
nadroparin Indicated for: prevention and treatment of thromboembolism
ketotifen Indicated for: allergic rhinitis; urticaria
budesonide Indicated for: asthma; inflammatory bowel disease
budesonide Indicated for: asthma; inflammatory bowel disease
budesonide Indicated for: asthma; inflammatory bowel disease
budesonide Indicated for: asthma; inflammatory bowel disease
budesonide Indicated for: asthma; inflammatory bowel disease
dimetindene Indicated for: allergic rhinitis; urticaria
clobazam Indicated for: epilepsy
N05BA09 Nervous system | Anxiolytics | Benzodiazepine derivatives
frovatriptan Indicated for: migraine
N02CC07 Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists